Arcus Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 9.73 M | $148.81 M | 100.00% | 10.65% |
| VANGUARD GROUP INC | 11/13/2024 | 5.47 M | $83.62 M | 4.02% | 5.98% |
| FMR LLC | 11/13/2024 | 4.47 M | $68.31 M | 6.86% | 4.89% |
| WOODLINE PARTNERS LP | 11/14/2024 | 3.48 M | $53.19 M | -18.06% | 3.81% |
| STATE STREET CORP | 11/14/2024 | 3.01 M | $46.04 M | -1.44% | 3.29% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 2.44 M | $37.26 M | 32.89% | 2.67% |
| SIREN, L.L.C. | 11/13/2024 | 1.61 M | $24.65 B | 100.00% | 1.76% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.60 M | $24.50 M | 0.00% | 1.75% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.52 M | $23.30 M | 3.00% | 1.67% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 1.32 M | $20.17 M | -10.52% | 1.44% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 1.30 M | $19.89 M | 3.19% | 1.42% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.22 M | $18.69 M | -0.88% | 1.34% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 1.03 M | $15.68 M | 146.85% | 1.12% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/08/2024 | 931,048 | $14.24 M | 25.09% | 1.02% |
| DECHENG CAPITAL LLC | 11/15/2024 | 869,790 | $13.30 M | 0.00% | 0.95% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 744,000 | $11.38 M | 413.10% | 0.81% |
| MORGAN STANLEY | 11/14/2024 | 714,456 | $10.92 M | 60.24% | 0.78% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 703,336 | $10.75 M | 10.45% | 0.77% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 673,838 | $10.30 M | 189.46% | 0.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 663,603 | $10.15 M | -30.68% | 0.73% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 566,979 | $8.67 M | 11.73% | 0.62% |
| MACQUARIE GROUP LTD | 11/14/2024 | 379,100 | $5.80 M | 0.00% | 0.41% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 357,838 | $5.47 M | -5.79% | 0.39% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 351,325 | $5.37 M | -11.25% | 0.38% |
| CITADEL ADVISORS LLC | 11/14/2024 | 317,871 | $4.86 M | -31.96% | 0.35% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 256,717 | $3.93 M | 1.38% | 0.28% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 255,611 | $3.91 M | -6.84% | 0.28% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 245,102 | $3.75 M | 39.50% | 0.27% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 238,544 | $3.65 M | 100.00% | 0.26% |
| AXA S.A. | 11/14/2024 | 232,266 | $3.55 M | 0.03% | 0.25% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 226,571 | $3.46 M | 408.82% | 0.25% |
| JANE STREET GROUP, LLC | 11/15/2024 | 217,041 | $3.32 M | 59.77% | 0.24% |
| NORDEA INVESTMENT MANAGEMENT AB | 11/05/2024 | 213,684 | $3.31 M | -4.58% | 0.23% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 187,415 | $2.87 M | 17.79% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 183,900 | $2.81 M | 123.18% | 0.20% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 175,000 | $2.68 M | 9.38% | 0.19% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 169,853 | $2.60 M | 1.53% | 0.19% |
| INVESCO LTD. | 11/12/2024 | 168,082 | $2.57 M | -7.87% | 0.18% |
| RHUMBLINE ADVISERS | 11/12/2024 | 161,835 | $2.47 M | -2.41% | 0.18% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 158,033 | $2.42 M | 564.87% | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 153,783 | $2.35 M | 0.00% | 0.17% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 151,044 | $2.31 M | -1.21% | 0.17% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 140,913 | $2.15 M | -0.43% | 0.15% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 135,659 | $2.07 M | 29.04% | 0.15% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2024 | 126,386 | $1.93 M | -8.43% | 0.14% |
| BARCLAYS PLC | 11/19/2024 | 118,693 | $1.82 M | 48.97% | 0.13% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/14/2024 | 114,399 | $1.75 M | -4.75% | 0.13% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 113,700 | $1.74 M | 100.00% | 0.12% |
| ALGERT GLOBAL LLC | 11/12/2024 | 112,847 | $1.73 M | 47.98% | 0.12% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 112,829 | $1.73 M | -54.06% | 0.12% |
Arcus Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 228 institutional investors and hedge funds held shares of Arcus Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 9.73 M
VANGUARD GROUP INC: 5.47 M
FMR LLC: 4.47 M
Woodline Partners LP: 3.48 M
STATE STREET CORP: 3.01 M
Point72 Asset Management, L.P.: 2.44 M
58.26% of Arcus Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 66.22 M shares in the last 24 months. This purchase volume represents approximately $1.00 B in transactions.